Eli Lilly & Co (LLY) SEC Filings — 2025
11 SEC filings for Eli Lilly & Co (LLY) in 2025.
Filings
- Eli Lilly & Co 8-K Filing — 8-K · Nov 21, 2025
- Eli Lilly's Q3 Revenue Soars 54%, Net Income Jumps 475% — 10-Q · Oct 30, 2025
- Eli Lilly Files 8-K on Debt Instruments — 8-K · Aug 20, 2025
- Eli Lilly's Q2 Soars on New Drug Sales, R&D Investment Continues — 10-Q · Aug 7, 2025
- Eli Lilly Files 8-K on Security Holder Votes and Debt — 8-K · May 8, 2025
- Eli Lilly Files Q1 2025 10-Q, Details Debt Maturities — 10-Q · May 1, 2025
- Eli Lilly Executive Compensation Details Revealed — DEF 14A · Mar 21, 2025
- Eli Lilly Files 2024 10-K, Details Financials — 10-K · Feb 19, 2025
- Eli Lilly Files 8-K Detailing Debt Offerings — 8-K · Feb 12, 2025
- Eli Lilly Files 8-K on Financials and Debt — 8-K · Feb 6, 2025
- Eli Lilly Files 8-K on Financials — 8-K · Jan 14, 2025